Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002
- PMID: 17638728
- DOI: 10.1001/archderm.143.7.854
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002
Abstract
Objective: To describe incidence trends for cutaneous T-cell lymphoma (CTCL) in the United States.
Design: Population-based study.
Setting: Data were obtained from 13 population-based cancer registries of the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute from 1973 through 2002.
Participants: A total of 4783 cases of CTCL were identified for the period 1973 through 2002.
Main outcome measure: Diagnosis of CTCL.
Results: The overall annual age-adjusted incidence of CTCL was 6.4 per million persons. Annual incidence increased by 2.9 x 10(-6) per decade over the study period. Incidence was higher among blacks (9.0 x 10(-6)) than among whites (6.1 x 10(-6)) and was higher among men (8.7 x 10(-6)) than among women (4.6 x 10(-6)). The racial differences in incidence decreased with age, while the sex differences increased with age and decreased over time. Substantial geographic variation in incidence was found. Incidence was correlated with high physician density, high family income, high percentage of population with a bachelor's degree or higher, and high home values. Changes in International Classification of Diseases for Oncology (ICD-O) morphologic definitions have resulted in the redistribution of the cases of CTCL among specific subclassifications.
Conclusions: The continued rise in incidence of CTCL is substantial, and the cause of this increase is unknown. The racial, ethnic, sex, and geographic differences in incidence may be of etiologic importance. Changes in ICD-O definitions have made it difficult to evaluate incidence trends for subclassifications of CTCL such as mycosis fungoides. In addition, these changes resulted in the creation of ambiguous histologic codes, which may have caused coding errors. These errors along with the lack of independent verification are limitations of our study. An epidemiological investigation using population-based data is important to better understand this disorder.
Comment in
-
Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States.Arch Dermatol. 2008 Mar;144(3):413-4. doi: 10.1001/archderm.144.3.413. Arch Dermatol. 2008. PMID: 18347305 No abstract available.
Comment on
-
Cutaneous T-cell lymphoma epidemiology: patients providing the power.Arch Dermatol. 2007 Jul;143(7):916-8. doi: 10.1001/archderm.143.7.916. Arch Dermatol. 2007. PMID: 17638738 No abstract available.
Similar articles
-
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. doi: 10.1093/jnci/dji289. J Natl Cancer Inst. 2005. PMID: 16204691
-
Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.Arch Dermatol. 2007 Jan;143(1):45-50. doi: 10.1001/archderm.143.1.45. Arch Dermatol. 2007. PMID: 17224541
-
Changing incidence trends of cutaneous T-cell lymphoma.JAMA Dermatol. 2013 Nov;149(11):1295-9. doi: 10.1001/jamadermatol.2013.5526. JAMA Dermatol. 2013. PMID: 24005876
-
Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.Clin Infect Dis. 2001 Sep 1;33(5):641-7. doi: 10.1086/322606. Epub 2001 Jul 30. Clin Infect Dis. 2001. PMID: 11486286 Review.
-
Infantile-onset cutaneous T-cell lymphoma.Br J Dermatol. 2008 Dec;159(6):1338-41. doi: 10.1111/j.1365-2133.2008.08794.x. Epub 2008 Aug 19. Br J Dermatol. 2008. PMID: 18717674 Review.
Cited by
-
Immunohistochemical Expression Patterns of CD45RO, p105/p50, JAK3, TOX, and IL-17 in Early-Stage Mycosis Fungoides.Diagnostics (Basel). 2022 Jan 17;12(1):220. doi: 10.3390/diagnostics12010220. Diagnostics (Basel). 2022. PMID: 35054387 Free PMC article.
-
Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma.Onco Targets Ther. 2019 Feb 7;12:1085-1094. doi: 10.2147/OTT.S165615. eCollection 2019. Onco Targets Ther. 2019. PMID: 30799938 Free PMC article. Review.
-
Update on Biology of Cutaneous T-Cell Lymphoma.Front Oncol. 2020 May 12;10:765. doi: 10.3389/fonc.2020.00765. eCollection 2020. Front Oncol. 2020. PMID: 32477957 Free PMC article. Review.
-
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.Front Oncol. 2018 Jun 4;8:198. doi: 10.3389/fonc.2018.00198. eCollection 2018. Front Oncol. 2018. PMID: 29915722 Free PMC article. Review.
-
Primary cutaneous lymphomas: A clinical and histological study of 99 cases in Isfahan, Iran.J Res Med Sci. 2015 Sep;20(9):827-31. doi: 10.4103/1735-1995.170595. J Res Med Sci. 2015. PMID: 26759567 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical